ESCALON MEDICAL CORP Quarterly Debt-to-equity in % from Q1 2012 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Escalon Medical Corp quarterly Debt-to-equity history and growth rate from Q1 2012 to Q4 2024.
  • Escalon Medical Corp Debt-to-equity for the quarter ending December 31, 2024 was 155 %, a 9.12% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 155 -15.5 -9.12% Dec 31, 2024
Q3 2024 165 -32.3 -16.4% Sep 30, 2024
Q2 2024 162 -71.9 -30.7% Jun 30, 2024
Q1 2024 165 -94.1 -36.3% Mar 31, 2024
Q4 2023 170 -124 -42.1% Dec 31, 2023
Q3 2023 197 -67.1 -25.4% Sep 30, 2023
Q2 2023 234 -1.53 -0.65% Jun 30, 2023
Q1 2023 260 +14.3 +5.84% Mar 31, 2023
Q4 2022 294 +42.1 +16.7% Dec 31, 2022
Q3 2022 264 -14.4 -5.18% Sep 30, 2022
Q2 2022 236 -79.6 -25.2% Jun 30, 2022
Q1 2022 245 -67.1 -21.5% Mar 31, 2022
Q4 2021 252 -13.3 -5% Dec 31, 2021
Q3 2021 278 +50.2 +22% Sep 30, 2021
Q2 2021 316 +141 +80.6% Jun 30, 2021
Q1 2021 312 +164 +111% Mar 31, 2021
Q4 2020 265 +126 +90.5% Dec 31, 2020
Q3 2020 228 +94.9 +71.1% Sep 30, 2020
Q2 2020 175 +37.4 +27.2% Jun 30, 2020
Q1 2020 148 +14.2 +10.6% Mar 31, 2020
Q4 2019 139 +6.91 +5.22% Dec 31, 2019
Q3 2019 133 -13.3 -9.08% Sep 30, 2019
Q2 2019 137 -43.7 -24.1% Jun 30, 2019
Q1 2019 134 -93.3 -41% Mar 31, 2019
Q4 2018 132 -147 -52.6% Dec 31, 2018
Q3 2018 147 -156 -51.6% Sep 30, 2018
Q2 2018 181 -94.4 -34.3% Jun 30, 2018
Q1 2018 227 -13 -5.4% Mar 31, 2018
Q4 2017 279 +78.4 +39.1% Dec 31, 2017
Q3 2017 303 +136 +81.4% Sep 30, 2017
Q2 2017 276 +133 +93.1% Jun 30, 2017
Q1 2017 240 +113 +88.6% Mar 31, 2017
Q4 2016 201 +75.4 +60.1% Dec 31, 2016
Q3 2016 167 +43.2 +35% Sep 30, 2016
Q2 2016 143 +17.5 +14% Jun 30, 2016
Q1 2016 127 +1.96 +1.56% Mar 31, 2016
Q4 2015 125 +8.4 +7.18% Dec 31, 2015
Q3 2015 124 +13.3 +12% Sep 30, 2015
Q2 2015 125 +22.4 +21.7% Jun 30, 2015
Q1 2015 126 +30.1 +31.5% Mar 31, 2015
Q4 2014 117 +29.1 +33.1% Dec 31, 2014
Q3 2014 110 +30.4 +38% Sep 30, 2014
Q2 2014 103 -38.3 -27.1% Jun 30, 2014
Q1 2014 95.4 -147 -60.6% Mar 31, 2014
Q4 2013 87.9 -333 -79.1% Dec 31, 2013
Q3 2013 80 -680 -89.5% Sep 30, 2013
Q2 2013 141 -231 -62.1% Jun 30, 2013
Q1 2013 242 -10.6 -4.2% Mar 31, 2013
Q4 2012 421 Dec 31, 2012
Q3 2012 760 Sep 30, 2012
Q2 2012 373 Jun 30, 2012
Q1 2012 253 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.